de Borst MH - Search Results

1

Urinary Oxalate Excretion and Long-Term Outcomes in Kidney Transplant Recipients.

Tubben A, Sotomayor CG, Post A, Minovic I, Frelink T, de Borst MH, Said MY, Douwes RM, van den Berg E, Rodrigo R, Berger SP, Navis GJ, Bakker SJL. Tubben A, et al. Among authors: de borst mh. J Clin Med. 2019 Dec 2;8(12):2104. doi: 10.3390/jcm8122104. J Clin Med. 2019. PMID: 31810202 Free PMC article.

2

Neonatal dexamethasone administration causes progressive renal damage due to induction of an early inflammatory response.

Liu Y, van Goor H, Havinga R, Baller JF, Bloks VW, van der Leij FR, Sauer PJ, Kuipers F, Navis G, de Borst MH. Liu Y, et al. Among authors: de borst mh. Am J Physiol Renal Physiol. 2008 Apr;294(4):F768-76. doi: 10.1152/ajprenal.00163.2007. Epub 2008 Jan 30. Am J Physiol Renal Physiol. 2008. PMID: 18234956 Free article.

3

c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.

de Borst MH, Prakash J, Sandovici M, Klok PA, Hamming I, Kok RJ, Navis G, van Goor H. de Borst MH, et al. J Pharmacol Exp Ther. 2009 Dec;331(3):896-905. doi: 10.1124/jpet.109.154179. Epub 2009 Aug 28. J Pharmacol Exp Ther. 2009. PMID: 19717791

4

Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.

Doorenbos CR, van den Born J, Navis G, de Borst MH. Doorenbos CR, et al. Among authors: de borst mh. Nat Rev Nephrol. 2009 Dec;5(12):691-700. doi: 10.1038/nrneph.2009.185. Epub 2009 Oct 27. Nat Rev Nephrol. 2009. PMID: 19859070 Review.

5

Dietary salt reductions and cardiovascular disease.

de Borst MH, Navis G. de Borst MH, et al. N Engl J Med. 2010 Jun 10;362(23):2224-5; author reply 2225-6. N Engl J Med. 2010. PMID: 20568307 No abstract available.

6

Vitamin D deficiency: universal risk factor for multifactorial diseases?

de Borst MH, de Boer RA, Stolk RP, Slaets JP, Wolffenbuttel BH, Navis G. de Borst MH, et al. Among authors: de boer ra. Curr Drug Targets. 2011 Jan;12(1):97-106. doi: 10.2174/138945011793591590. Curr Drug Targets. 2011. PMID: 20795934 Review.

7

Vitamin D in chronic kidney disease: new potential for intervention.

Mirković K, van den Born J, Navis G, de Borst MH. Mirković K, et al. Among authors: de borst mh. Curr Drug Targets. 2011 Jan;12(1):42-53. doi: 10.2174/138945011793591572. Curr Drug Targets. 2011. PMID: 20795938 Review.

8

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.

de Borst MH, Vervloet MG, ter Wee PM, Navis G. de Borst MH, et al. J Am Soc Nephrol. 2011 Sep;22(9):1603-9. doi: 10.1681/ASN.2010121251. Epub 2011 Aug 18. J Am Soc Nephrol. 2011. PMID: 21852584 Free PMC article.

9

Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.

Doorenbos CR, de Cuba MM, Vogt L, Kema IP, van den Born J, Gans RO, Navis G, de Borst MH. Doorenbos CR, et al. Among authors: de borst mh, de cuba mm. J Steroid Biochem Mol Biol. 2012 Jan;128(1-2):56-61. doi: 10.1016/j.jsbmb.2011.09.002. Epub 2011 Sep 21. J Steroid Biochem Mol Biol. 2012. PMID: 21958677

10

Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.

Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, Hepkema BG, Reznichenko A, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA. Damman J, et al. Among authors: de borst mh. Mol Immunol. 2012 Feb;50(1-2):1-8. doi: 10.1016/j.molimm.2011.11.009. Epub 2011 Dec 15. Mol Immunol. 2012. PMID: 22173059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page